published in Huisarts Nu 2004 (4):182-198

1. Opportunistic screening of women decreases the number of complications (level of evidence 2).
2. Opportunistic screening should, by consensus, be offered to:
   1. Women under 35 who have had more than one sexual partner in the past year or who have a new partner for less than six months;
   2. Women who will undergo an abortion.
3. Furthermore it is advised to offer a test for Chlamydia trachomatis to:
   1. All women with one or more of the following risk factors:
      postcoital or intermenstrual bleeding, painful micturition which continues after empirical treatment for a bladder infection, having a partner who complains of dysuria
   2. All men who suffer from dysuria or who have complaints related to urethritis.
4. Screening should be performed using Nucleic Acid Amplified Testing (NAAT) (level of evidence 1) on a first voided urine sample or a vaginal swab. 
5.  A positive result must be confirmed by a second amplification test, unless the clinical history is suggestive for an STD.
6. An uncomplicated infection in a non-pregnant woman is treated with a single dose of 1g azithromycin (level of evidence 1). 
7.  The partner(s) of an infected patient must also receive treatment.